Quick Pulse Summary The Big Thing Headline: GLP-1 drugs enter a new phase: safety signals, lawsuits, and regulation now shape the conversation. What happened (plain English):GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound are no longer just breakthrough weight-loss drugs — they are now at the center of regulatory action, safety monitoring, and legal scrutiny.
March 31, 2026
